{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T10:31:03Z","timestamp":1784802663848,"version":"3.55.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T00:00:00Z","timestamp":1704153600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T00:00:00Z","timestamp":1704153600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Griffith University Health Group","award":["2019"],"award-info":[{"award-number":["2019"]}]},{"name":"Griffith University Health Group","award":["2019"],"award-info":[{"award-number":["2019"]}]},{"name":"Griffith University Health Group","award":["2019"],"award-info":[{"award-number":["2019"]}]},{"name":"Griffith University Health Group","award":["2019"],"award-info":[{"award-number":["2019"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Health Qual Life Outcomes"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Peripheral intravenous catheters (PIVCs) are essential for successful administration of intravenous treatments. However, insertion failure and PIVC complications are common and negatively impact patients\u2019 health-outcomes and experiences. We aimed to assess whether generic (not condition-specific) quality of life and experience measures were suitable for assessing outcomes and experiences of patients with PIVCs.\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We undertook a secondary analysis of data collected on three existing instruments within a large randomised controlled trial, conducted at two adult tertiary hospitals in Queensland, Australia. Instruments included the EuroQol Five Dimension - Five Level (EQ5D-5L), the Functional Assessment of Chronic Illness Therapy \u2013 Treatment Satisfaction \u2013 General measure (FACIT-TS-G, eight items), and the Australian Hospital Patient Experience Question Set (AHPEQS, 12 items). Responses were compared against two clinical PIVC outcomes of interest: all-cause failure and multiple insertion attempts. Classic descriptives were reported for ceiling and floor effects. Regression analyses examined validity (discrimination). Standardised response mean and effect size (ES) assessed responsiveness (EQ5D-5L, only).\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In total, 685 participants completed the EQ5D-5L at insertion and 526 at removal. The FACIT-TS-G was completed by 264 and the AHPEQS by 262 participants. Two FACIT-TS-G items and one AHPEQS item demonstrated ceiling effect. Instruments overall demonstrated poor discrimination, however, all-cause PIVC failure was significantly associated with several <jats:italic>individual<\/jats:italic> items in the instruments (e.g., AHPEQS, \u2018<jats:italic>unexpected physical and emotional harm\u2019<\/jats:italic>). EQ5D-5L demonstrated trivial (ES\u2009&lt;\u20090.20) responsiveness.\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Initial investigation of an existing health-related quality of life measure (EQ5D-5L) and two patient-reported experience measures (FACIT-TS-G; AHPEQS) suggest they are inadequate (as a summary measure) to assess outcomes and experiences for patients with PIVCs. Reliable instruments are urgently needed to inform quality improvement and benchmark standards of care.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12955-023-02217-8","type":"journal-article","created":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T19:02:58Z","timestamp":1704222178000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Health-related quality of life and experience measures, to assess patients\u2019 experiences of peripheral intravenous catheters: a secondary data analysis"],"prefix":"10.1186","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6272-8484","authenticated-orcid":false,"given":"Emily N.","family":"Larsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5779-1304","authenticated-orcid":false,"given":"Nicole","family":"Marsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6341-7415","authenticated-orcid":false,"given":"Claire M.","family":"Rickard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6654-405X","authenticated-orcid":false,"given":"Gabor","family":"Mihala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6089-8225","authenticated-orcid":false,"given":"Rachel M.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6562-711X","authenticated-orcid":false,"given":"Joshua","family":"Byrnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,2]]},"reference":[{"key":"2217_CR1","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/S0924-8579(09)70565-5","volume":"34","author":"W Zingg","year":"2009","unstructured":"Zingg W, Pittet D. Peripheral venous catheters: an under-evaluated problem. Int J Antimicrob. 2009;34:38\u2013S42.","journal-title":"Int J Antimicrob"},{"issue":"2","key":"2217_CR2","doi-asserted-by":"publisher","first-page":"83","DOI":"10.12788\/jhm.2867","volume":"13","author":"N Marsh","year":"2018","unstructured":"Marsh N, Webster J, Larsen E, Cooke M, Mihala G, Rickard CM. Observational study of Peripheral Intravenous catheter outcomes in adult hospitalized patients: a multivariable analysis of Peripheral Intravenous catheter failure. J Hosp Med. 2018;13(2):83\u20139.","journal-title":"J Hosp Med"},{"issue":"3","key":"2217_CR3","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1007\/s00520-020-05643-2","volume":"29","author":"EN Larsen","year":"2021","unstructured":"Larsen EN, Marsh N, O\u2019Brien C, Monteagle E, Friese C, Rickard CM. Inherent and modifiable risk factors for peripheral venous catheter failure during cancer treatment: a prospective cohort study. Support Care Cancer. 2021;29(3):1487\u201396.","journal-title":"Support Care Cancer"},{"issue":"19","key":"2217_CR4","doi-asserted-by":"publisher","first-page":"18","DOI":"10.12968\/bjon.2017.26.19.S18","volume":"26","author":"E Larsen","year":"2017","unstructured":"Larsen E, Keogh S, Marsh N, Rickard C. Experiences of peripheral IV insertion in hospital: a qualitative study. Br J Nurs. 2017;26(19):18\u2013S25.","journal-title":"Br J Nurs"},{"key":"2217_CR5","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.jss.2018.08.015","volume":"233","author":"CN Patel","year":"2019","unstructured":"Patel CN, Swartz MD, Tomasek JS, Vincent LE, Hallum WE, Holcomb JB. The effects of missed doses of antibiotics on hospitalized patient outcomes. J Surg Res. 2019;233:276\u201383.","journal-title":"J Surg Res"},{"issue":"2","key":"2217_CR6","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1097\/NAN.0b013e31824237ce","volume":"35","author":"SS Dychter","year":"2012","unstructured":"Dychter SS, Gold DA, Carson D, Haller M. Intravenous therapy: a review of Complications and economic considerations of peripheral access. J Infus Nurs. 2012;35(2):84\u201391.","journal-title":"J Infus Nurs"},{"issue":"3","key":"2217_CR7","first-page":"e178","volume":"100","author":"P Saliba","year":"2018","unstructured":"Saliba P, Hornero A, Cuervo G, Grau I, Jimenez E, Berbel D, et al. Interventions to decrease short-term peripheral venous catheter-related bloodstream Infections: impact on incidence and mortality. J Hosp Med. 2018;100(3):e178\u2013e86.","journal-title":"J Hosp Med"},{"issue":"1","key":"2217_CR8","first-page":"86","volume":"94","author":"D Rhodes","year":"2016","unstructured":"Rhodes D, Cheng A, McLellan S, Guerra P, Karanfilovska D, Aitchison S, et al. Reducing Staphylococcus aureus bloodstream Infections associated with peripheral intravenous cannulae: successful implementation of a care bundle at a large Australian health service. J Hosp Med. 2016;94(1):86\u201391.","journal-title":"J Hosp Med"},{"issue":"6","key":"2217_CR9","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1016\/j.jpainsymman.2009.05.025","volume":"39","author":"CS Cleeland","year":"2010","unstructured":"Cleeland CS, Sloan JA, Group AO. Assessing the symptoms of cancer using patient-reported outcomes (ASCPRO): searching for standards. J Pain Symptom Manage. 2010;39(6):1077\u201385.","journal-title":"J Pain Symptom Manage"},{"issue":"1","key":"2217_CR10","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s00520-017-3865-7","volume":"26","author":"LY Yang","year":"2018","unstructured":"Yang LY, Manhas DS, Howard AF, Olson R. Patient-reported outcome use in oncology: a systematic review of the impact on patient-clinician communication. Support Care Cancer. 2018;26(1):41\u201360.","journal-title":"Support Care Cancer"},{"key":"2217_CR11","first-page":"HSI","volume":"6","author":"T Weldring","year":"2013","unstructured":"Weldring T, Smith SM. Article commentary: patient-reported outcomes (pros) and patient-reported outcome measures (PROMs). Health Serv Insights. 2013;6:HSI.","journal-title":"Health Serv Insights"},{"issue":"Supplement1","key":"2217_CR12","doi-asserted-by":"publisher","first-page":"ii3","DOI":"10.1093\/intqhc\/mzab002","volume":"34","author":"K de Bienassis","year":"2022","unstructured":"de Bienassis K, Kristensen S, Hewlett E, Roe D, Mainz J, Klazinga N. Measuring patient voice matters: setting the scene for patient-reported indicators. Int J Qual Health Care. 2022;34(Supplement1):ii3\u2013ii6.","journal-title":"Int J Qual Health Care"},{"key":"2217_CR13","unstructured":"Larsen E, Wickins J, Marsh N, Byrnes J, Rickard C. Patient reported outcomes and experiences for peripheral venous catheters: A scoping review. (In draft)"},{"key":"2217_CR14","unstructured":"Australian Hospital Patient Experience Question Set: Australian Commission on Safety and Quality in Health Care. ; 2019 [Available from: https:\/\/www.safetyandquality.gov.au\/our-work\/indicators-measurement-and-reporting\/australian-hospital-patient-experience-question-set]. Accessed 16 Dec 2022."},{"key":"2217_CR15","unstructured":"Questionnaires FACITorg. FACIT.org; 2020 [Available from: https:\/\/www.facit.org\/]. Accessed 16 Dec 2022."},{"key":"2217_CR16","unstructured":"EQ-5D Instruments: EuroQol Research Foundcation. ; 2020 [Available from: https:\/\/euroqol.org\/eq-5d-instruments\/.] Accessed 16 Dec 2022."},{"key":"2217_CR17","doi-asserted-by":"crossref","unstructured":"Rickard C, Larsen E, Walker R, Mihala G, Byrnes J, Saiyed M et al. Integrated versus nonintegrated peripheral intravenous catheter in hospitalized adults (OPTIMUM): a randomized controlled trial. J Hosp Med. 2022;18(1):21\u201332.","DOI":"10.1002\/jhm.12995"},{"issue":"10145","key":"2217_CR18","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/S0140-6736(18)31380-1","volume":"392","author":"CM Rickard","year":"2018","unstructured":"Rickard CM, Marsh N, Webster J, Runnegar N, Larsen E, McGrail MR, et al. Dressings and securements for the prevention of peripheral intravenous catheter failure in adults (SAVE): a pragmatic, randomised controlled, superiority trial. Lancet. 2018;392(10145):419\u201330.","journal-title":"Lancet"},{"issue":"2","key":"2217_CR19","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s40258-017-0310-5","volume":"15","author":"NJ Devlin","year":"2017","unstructured":"Devlin NJ, Brooks R. EQ-5D and the EuroQol group: past, present and future. Appl Health Econ Health Policy. 2017;15(2):127\u201337.","journal-title":"Appl Health Econ Health Policy"},{"issue":"2","key":"2217_CR20","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s10926-014-9547-0","volume":"25","author":"M-C Hung","year":"2015","unstructured":"Hung M-C, Lu W-S, Chen S-S, Hou W-H, Hsieh C-L, Wang J-D. Validation of the EQ-5D in patients with traumatic limb injury. J Occup Rehabil. 2015;25(2):387\u201393.","journal-title":"J Occup Rehabil"},{"issue":"1","key":"2217_CR21","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s11136-004-0614-4","volume":"14","author":"D Nowels","year":"2005","unstructured":"Nowels D, McGloin J, Westfall JM, Holcomb S. Validation of the EQ-5D quality of life instrument in patients after Myocardial Infarction. Qual Life Res. 2005;14(1):95\u2013105.","journal-title":"Qual Life Res"},{"issue":"8","key":"2217_CR22","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1111\/j.1524-4733.2009.00581.x","volume":"12","author":"R Norman","year":"2009","unstructured":"Norman R, Cronin P, Viney R, King M, Street D, Ratcliffe J. International comparisons in valuing EQ-5D health states: a review and analysis. Value Health. 2009;12(8):1194\u2013200.","journal-title":"Value Health"},{"issue":"6","key":"2217_CR23","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1016\/j.jval.2011.04.009","volume":"14","author":"R Viney","year":"2011","unstructured":"Viney R, Norman R, King MT, Cronin P, Street DJ, Knox S, et al. Time trade-off derived EQ-5D weights for Australia. Value Health. 2011;14(6):928\u201336.","journal-title":"Value Health"},{"key":"2217_CR24","unstructured":"Centers for Disease Control and Prevention (CDC). CDC\/National Healthcare Safety Network Surveillance definition of healthcare-associated infection and criteria for specific types of infections in the acute care setting. 2022. [Available from: https:\/\/www.cdc.gov\/nhsn\/pdfs\/pscmanual\/17pscnosinfdef_current.pdf]. Accessed 21 Mar 2023."},{"issue":"8","key":"2217_CR25","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/j.jval.2012.08.2201","volume":"15","author":"D Rowen","year":"2012","unstructured":"Rowen D, Young T, Brazier J, Gaugris S. Comparison of generic, condition-specific, and mapped health state utility values for Multiple Myeloma cancer. Value Health. 2012;15(8):1059\u201368.","journal-title":"Value Health"},{"key":"2217_CR26","doi-asserted-by":"publisher","first-page":"3399","DOI":"10.1007\/s11136-017-1666-6","volume":"26","author":"S Kularatna","year":"2017","unstructured":"Kularatna S, Byrnes J, Chan YK, Ski CF, Carrington M, Thompson D, Stewart S, Scuffham PA. Comparison of the EQ-5D-3L and the SF-6D (SF-12) contemporaneous utility scores in patients with Cardiovascular Disease. Qual Life Res. 2017;26:3399\u2013408.","journal-title":"Qual Life Res"},{"key":"2217_CR27","doi-asserted-by":"publisher","DOI":"10.1007\/978-94-007-0753-5_1581","volume-title":"Encyclopedia of Quality of Life and Well-Being Research","author":"M Davidson","year":"2014","unstructured":"Davidson M. Known-groups validity. In: Michalos AC, editor. Encyclopedia of Quality of Life and Well-Being Research. Dordrecht: Springer; 2014. https:\/\/doi.org\/10.1007\/978-94-007-0753-5_1581."},{"key":"2217_CR28","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.jclinepi.2021.06.002","volume":"140","author":"L Mokkink","year":"2012","unstructured":"Mokkink L, Terwee C, de Vet H. Key concepts in clinical epidemiology: responsiveness, the longitudinal aspect of validity. J Clin Epidemiol. 2012;140:159\u201362.","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"2217_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1477-7525-1-4","volume":"1","author":"SJ Walters","year":"2003","unstructured":"Walters SJ, Brazier JE. What is the relationship between the minimally important difference and health state utility values? The case of the SF-6D. Health Qual Life Outcomes. 2003;1(1):1\u20138.","journal-title":"Health Qual Life Outcomes"},{"key":"2217_CR30","doi-asserted-by":"crossref","unstructured":"Middel B, Van Sonderen E. Statistical significant change versus relevant or important change in (quasi) experimental design: some conceptual and methodological problems in estimating magnitude of intervention-related change in health services research. Int J Integr Care. 2002;2:e15.","DOI":"10.5334\/ijic.65"},{"issue":"1","key":"2217_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2288-10-22","volume":"10","author":"LB Mokkink","year":"2010","unstructured":"Mokkink LB, Terwee CB, Knol DL, Stratford PW, Alonso J, Patrick DL, et al. The COSMIN checklist for evaluating the methodological quality of studies on measurement properties: a clarification of its content. BMC Med Res Methodol. 2010;10(1):1\u20138.","journal-title":"BMC Med Res Methodol"},{"key":"2217_CR32","doi-asserted-by":"publisher","first-page":"102413","DOI":"10.1016\/j.msard.2020.102413","volume":"45","author":"E Engebretson","year":"2020","unstructured":"Engebretson E, Seale RA, Valdez B, Vollmer TL, Medina LD. Validation of the functional assessment of chronic Illness therapy\u2013general treatment satisfaction (FACIT-TS-G) in multiple sclerosis. Mult Scler Relat Disord. 2020;45:102413.","journal-title":"Mult Scler Relat Disord"},{"issue":"2","key":"2217_CR33","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1093\/cid\/ciab352","volume":"74","author":"V-T Tran","year":"2022","unstructured":"Tran V-T, Riveros C, Clepier B, Desvarieux M, Collet C, Yordanov Y, et al. Development and validation of the Long Coronavirus Disease (COVID) Symptom and Impact Tools: a set of patient-reported instruments constructed from patients\u2019 lived experience. Clin Infect Dis. 2022;74(2):278\u201387.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"2217_CR34","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1007\/s11136-013-0520-8","volume":"23","author":"JD Peipert","year":"2014","unstructured":"Peipert JD, Beaumont JL, Bode R, Cella D, Garcia SF, Hahn EA. Development and validation of the functional assessment of chronic Illness therapy treatment satisfaction (FACIT TS) measures. Qual Life Res. 2014;23(3):815\u201324.","journal-title":"Qual Life Res"},{"issue":"7","key":"2217_CR35","doi-asserted-by":"publisher","first-page":"A284","DOI":"10.1016\/j.jval.2012.08.513","volume":"15","author":"A Leunis","year":"2012","unstructured":"Leunis A, Redekop W, Lowenberg B, Uyl-de Groot C. UT1 the calculation of quality of Life Utilities for Acute Leukemia: a comparison between eq.\u00a05D-5L and QlQ-C30. Value Health. 2012;15(7):A284.","journal-title":"Value Health"},{"key":"2217_CR36","doi-asserted-by":"crossref","unstructured":"Nelson HJ, Pienaar C, McKenzie K, Williams AM, Swaminathan G, M\u04e7relius E. Development of the Australian hospital patient experience question set for parents. Collegian. 2023;30(2):13\u2013221.","DOI":"10.1016\/j.colegn.2022.09.003"},{"issue":"6","key":"2217_CR37","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1111\/sms.13908","volume":"31","author":"KB Christensen","year":"2021","unstructured":"Christensen KB, Comins JD, Krogsgaard MR, Brodersen J, Jensen J, Hansen CF, et al. Psychometric validation of PROM instruments. Scand J Med Sci Sports. 2021;31(6):1225\u201338.","journal-title":"Scand J Med Sci Sports"},{"issue":"1","key":"2217_CR38","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1097\/NAN.0000000000000408","volume":"44","author":"A Plohal","year":"2021","unstructured":"Plohal A. A qualitative study of adult hospitalized patients with difficult venous access experiencing short peripheral catheter insertion in a hospital setting. J Infus Nurs. 2021;44(1):26\u201333.","journal-title":"J Infus Nurs"},{"issue":"1","key":"2217_CR39","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1891\/1061-3749.4.1.59","volume":"4","author":"KJ Aroian","year":"1996","unstructured":"Aroian KJ, Schappler-Morris N. Using qualitative data for estimating construct validity of standardized measures. J Nurs Meas. 1996;4(1):59\u201374.","journal-title":"J Nurs Meas"}],"container-title":["Health and Quality of Life Outcomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12955-023-02217-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12955-023-02217-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12955-023-02217-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T19:07:52Z","timestamp":1704222472000},"score":1,"resource":{"primary":{"URL":"https:\/\/hqlo.biomedcentral.com\/articles\/10.1186\/s12955-023-02217-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,2]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2217"],"URL":"https:\/\/doi.org\/10.1186\/s12955-023-02217-8","relation":{},"ISSN":["1477-7525"],"issn-type":[{"value":"1477-7525","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,2]]},"assertion":[{"value":"10 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"for this secondary analysis was obtained from the Royal Brisbane and Women\u2019s Hospital Human Research Ethics Committee (HREC\/16\/QRBW\/527, Amendment 09) and Griffith University Human Research Ethics Committee (Ref no. 2016\/239). All participants provided written informed consent to participate in the larger RCT; completion of the supplementary instruments demonstrated participants\u2019 implied consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"EL\u2019s affiliate (University of Queensland) has received, on her behalf: an investigator-initiated research grant from Eloquest Healthcare, unrelated to this work; EL was also awarded scholarship for conference attendance, by Angiodynamics, unrelated to this work.NM: Griffith University or The University of Queensland has received on her behalf: investigator-initiated research grants and unrestricted educational grants from Becton Dickinson, Cardinal Health, and Eloquest Healthcare; and consultancy payments for educational lectures\/expert advice from Becton Dickinson and 3M.CMR\u2019s employers (Griffith University or The University of Queensland) have received on her behalf: investigator-initiated research or educational\u00a0grants from 3M, Becton Dickinson-Bard; Cardinal Health, Eloquest Healthcare; and consultancy payments for educational lectures\/expert advice from 3M, Becton Dickinson-Bard, ITL Biomedical.RMW has received research grant funding for this project and another investigator-initiated research grant provided to Griffith University by vascular access product manufacturer Becton Dickinson and Company. However, they had no role in study design, data collection or analysis, or in the decision to publish or preparation of manuscript.GM was a recipient of a Higher Degree Research Scholarship from the Australian Government Research Training Program between 2019 and 2022.JB\u2019s employer, Griffith University, has received on his behalf: an investigator-initiated grant-in-aid from BD-Bard, NeoNav, 3M, Edwards Life Sciences and Abbott.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1"}}